Plenary Session

5.32 - ASH Update #1 - Talquetamab NEJM

12.11.2022 - By Vinay Prasad, MD MPHPlay

Download our free app to listen on your phone

Download on the App StoreGet it on Google Play

Is it acceptable to take someone with myeloma who has gotten just 2 regimens and put them on a phase 1? VP says hell no.

More episodes from Plenary Session